C. Wright

发表

Inhibition of terfenadine metabolism in vitro by azole antifungal agents and by selective serotonin reuptake inhibitor antidepressants: relation to pharmacokinetic interactions in vivo.

D. Greenblatt, J. Harmatz, R. Shader, 1996, Journal of clinical psychopharmacology.

Interaction of triazolam and ketoconazole

D. Greenblatt, J. Harmatz, R. Shader, 1995, The Lancet.

Effect of the bile‐acid sequestrant colestipol on postprandial serum bile‐acid concentration: evaluation by bioluminescent enzymic analysis

A. Hofmann, N. Andreadis, A. Hofmann, 1989, Alimentary pharmacology & therapeutics.

A Pharmacokinetic Evaluation of the Combined Administration of Triazolam and Fluoxetine

R. Steenwyk, C. Wright, C. N. Swanson, 1992, Pharmacotherapy.

Clinical Pharmacokinetics of Alprazolam

David J. Greenblatt, D. Greenblatt, C. Eugene Wright, 1993, Clinical pharmacokinetics.

Midazolam Hydroxylation by Human Liver Microsomes In Vitro: Inhibition by Fluoxetine, Norfluoxetine, and by Azole Antifungal Agents

D. Greenblatt, J. Harmatz, R. Shader, 1996, Journal of clinical pharmacology.

Ketoconazole inhibition of triazolam and alprazolam clearance: Differential kinetic and dynamic consequences

D. Greenblatt, B. Ehrenberg, J. Harmatz, 1998, Clinical pharmacology and therapeutics.

In vitro approaches to predicting drug interactions in vivo.

D. Greenblatt, J. Harmatz, R. Shader, 1998, Biochemical pharmacology.

Age and gender effects on the pharmacokinetics and pharmacodynamics of triazolam, a cytochrome P450 3A substrate

D. Greenblatt, J. Harmatz, R. Shader, 2004, Clinical pharmacology and therapeutics.

Pharmacokinetic and Pharmacodynamic Comparison of Immediate-Release and Sustained-Release Adinazolam Mesylate Tablets After Single- and Multiple-Dose Administration

J. Fleishaker, C. Wright, 1992, Pharmaceutical Research.

Pharmacokinetics and Psychomotor Performance of Alprazolam: Concentration—Effect Relationship

E. Antal, J. Fleishaker, C. Wright, 1997, Journal of clinical pharmacology.

Clinical pharmacokinetics of alprazolam extended release: a summary

C. Wright, 1995 .

Triazolam biotransformation by human liver microsomes in vitro: effects of metabolic inhibitors and clinical confirmation of a predicted interaction with ketoconazole.

J S Harmatz, D J Greenblatt, D. Greenblatt, 1996, The Journal of pharmacology and experimental therapeutics.

Minoxidil analysis in human plasma using high-performance liquid chromatography with electrochemical detection. Application to pharmacokinetic studies.

D. Abernethy, G. Carrum, C. Wright, 1986, Journal of chromatography.

543 The comparative bioavailability of two international medroxyprogesterone acetate (MPA) sterile suspension products after oral and intramuscular administration

E. Antal, K. Albert, C. Wright, 1983 .

Pharmacokinetics in lactating women: prediction of alprazolam transfer into milk.

P. McNamara, C. Oo, R. Kuhn, 1995, British journal of clinical pharmacology.

Human cytochromes mediating N-demethylation of fluoxetine in vitro

D. Greenblatt, J. Harmatz, R. Shader, 1997, Psychopharmacology.

Comparison of pramipexole, fluoxetine, and placebo in patients with major depression

Dwight L. Evans, C. Wright, M. Corrigan, 2000, Depression and anxiety.

Effect of injection volume on the bioavailability of sterile medroxyprogesterone acetate suspension.

E. Antal, K. Albert, W. Gillespie, 1983, Clinical pharmacy.

Inhibition of triazolam clearance by macrolide antimicrobial agents: In vitro correlates and dynamic consequences

D. Greenblatt, J. Harmatz, R. Shader, 1998, Clinical pharmacology and therapeutics.

The Pharmacokinetics of 2.5‐ to 10‐mg Oral Doses of Minoxidil in Healthy Volunteers

N. Andreadis, J. Fleishaker, I. Welshman, 1989, Journal of clinical pharmacology.

Disposition of Minoxidil in Patients with Various Degrees of Renal Function

G. Matzke, C. Halstenson, J. Opsahl, 1989, Journal of clinical pharmacology.

Single- and multiple-dose pharmacokinetics of oral alprazolam in healthy smoking and nonsmoking men.

P. Gwilt, C. Wright, R. Smith, 1983, Clinical pharmacy.

A comparative pharmacokinetic and dynamic evaluation of alprazolam sustained-release, bromazepam, and lorazepam.

D. Greenblatt, E. Sellers, U. Busto, 2000, Journal of clinical psychopharmacology.

Comparative kinetics and response to the benzodiazepine agonists triazolam and zolpidem: evaluation of sex-dependent differences.

D. Greenblatt, J. Harmatz, R. Shader, 2000, The Journal of pharmacology and experimental therapeutics.

Absorption kinetics of rectally and orally administered ibuprofen.

M. Eller, C. Wright, A. Della-Coletta, 1989, Biopharmaceutics & drug disposition.

Influence of route of administration on the pharmacokinetics of methylprednisolone

E. Antal, K. Albert, W. Gillespie, 1983, Journal of Pharmacokinetics and Biopharmaceutics.

Alprazolam in young and elderly men: sensitivity and tolerance to psychomotor, sedative and memory effects.

F. Salek, P. Kroboth, I. Reynolds, 1997, The Journal of pharmacology and experimental therapeutics.

Steady‐State Pharmacokinetic Properties of Pramipexole in Healthy Volunteers

C. Wright, G. Peters, A. K. Ichhpurani, 1997, Journal of clinical pharmacology.

The Influence of Hemodialysis on the Pharmacokinetics of Ibuprofen and Its Major Metabolites

E. Antal, K. Albert, C. Wright, 1986, Journal of clinical pharmacology.

Comparative bioavailability of two medroxyprogesterone acetate suspensions

E. Antal, I. Welshman, C. Wright, 1989 .

Ibuprofen and acetaminophen kinetics when taken concurrently

E. Antal, K. Albert, W. Gillespie, 1983, Clinical pharmacology and therapeutics.

Do Alprazolam‐Induced Changes in Saccadic Eye Movement and Psychomotor Function Follow the Same Time Course?

J. Sweeney, P. Kroboth, K. Bauer, 1998, Journal of clinical pharmacology.